Opportunity Analysis for Biosimilars - South Korea

Patent Expiry of Biologics to Provide Potential Growth for Biosimilars


This research service presents an overview of the South Korean biosimilars market and analyzes the opportunities that lay ahead for different stakeholders in the development, manufacturing, and commercialization of biosimilars. This service divides the market into therapeutic proteins and monoclonal antibodies. Further, it aims to present an overview of the global biosimilars market and covers impending patent expiries for biologics, regulatory guidelines, pipeline data, and important participants in the market. Moreover, key market challenges, drivers, and restraints are discussed. The forecast period extends through 2015, with a base year of 2010.

Regular Price: USD 4,950

Special Price USD 3,713

25% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,713

PAY BY INVOICE

Be the first to review this product

Table of Contents

Opportunity Analysis for Biosimilars - South Korea, IntroductionOpportunity AnalysisSouth Korea Biosimilars Market




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.